Revolution Medicines price target raised to $62 from $56 at H.C. Wainwright
PremiumThe FlyRevolution Medicines price target raised to $62 from $56 at H.C. Wainwright
6d ago
Revolution Medicines price target raised to $82 from $72 at Guggenheim
Premium
The Fly
Revolution Medicines price target raised to $82 from $72 at Guggenheim
13d ago
Revolution Medicines price target raised to $60 from $55 at Oppenheimer
Premium
The Fly
Revolution Medicines price target raised to $60 from $55 at Oppenheimer
13d ago
Revolution Medicines price target raised to $60 from $54 at Barclays
PremiumThe FlyRevolution Medicines price target raised to $60 from $54 at Barclays
1M ago
Revolution Medicines participates in a conference call with JPMorgan
Premium
The Fly
Revolution Medicines participates in a conference call with JPMorgan
2M ago
Revolution Medicines added to Analyst Focus List at JPMorgan
Premium
The Fly
Revolution Medicines added to Analyst Focus List at JPMorgan
2M ago
Revolution Medicines reports Q2 EPS (81c), consensus (77c)
PremiumThe FlyRevolution Medicines reports Q2 EPS (81c), consensus (77c)
3M ago
Revolution Medicines price target raised to $54 from $52 at Barclays
Premium
The Fly
Revolution Medicines price target raised to $54 from $52 at Barclays
4M ago
Revolution Medicines price target raised to $55 from $45 at Oppenheimer
Premium
The Fly
Revolution Medicines price target raised to $55 from $45 at Oppenheimer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100